The Human 8-oxoG DNA Glycosylase 1 (OGG1) Ser326Cys Polymorphism in Infertile Men
Electrical bioimpedance spectroscopy (EBiS) was performed using our bioimpedance analyzer at the Instituto Politécnico Nacional, Mexico City.
FAST. PRECISE. PATIENT-SAFE.
You want to use impedance spectroscopy in a medical research application? You like it simple, precise and fast and you don't want to worry about patient safety? Then check out the Medical Research ISX-3 impedance analyzer.
It bases on our ISX-3 impedance analyzer. It is equipped with Sciospec’s IF frontend with 4-port BNC interface supporting simple 2 point measurements, as well as 3 and 4 electrode configurations. Within the measurement range from 100 mHz to 10 MHz (extendable to 40 or 100 MHz) it covers a dynamic range of 300dB (mOhm…TOhm) with a base precision of 0.01%.
Additionally the Medical Research ISX-3 includes measures for enhanced electrical safety including medical grade isolation enabling a safe operation of the instrument in medical research settings.
Electrical bioimpedance spectroscopy (EBiS) was performed using our bioimpedance analyzer at the Instituto Politécnico Nacional, Mexico City.
Our ISX-3 impedance analyzer in a challenging application at the University of Rostock, Germany
Our ISX-3 enables precise multi-frequency skin impedance measurements offering enhanced electrodermal activity analysis for our customers.
Our ISX-5 impedance analyzer in an interesting application at the University of Dhaka, Dhaka, Bangladesh.
In a very simple setup we used the Medical Research ISX-3 with a 32-channel MUX to measure the forearm impedance change caused movements of the hand.
The ISX-3 impedance analyzer is not a medical product and as such its intended purpose does not include diagnosis and/or treatment of patients. But the Medical Research ISX-3 includes several added safety measures specified in accordance with DIN EN 60601-1:2013-12 "Medical electrical equipment – Part 1: General requirements for basic safety and essential performance". These measures ease the application for excemptions for experiments on patients.
John Doe Tweet
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information